Sign in
4

Changes in Ownership

Atara Biotherapeutics, Inc. Filed Acc 0001209191-19-003315

Chief Executive Officer sold 7,800 shares at an average $34.55 ($269,470)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Ciechanover Isaac E. Chief Executive Officer 2019-01-09 Sale −1,900 $34.51 $65,569 9,978 I: show line 1 in the form
Ciechanover Isaac E. Chief Executive Officer 2019-01-09 Sale −2,000 $35.16 $70,320 7,978 I: show line 2 in the form
Ciechanover Isaac E. Chief Executive Officer 2019-01-10 Sale −1,700 $33.93 $57,681 6,278 I: show line 3 in the form
Ciechanover Isaac E. Chief Executive Officer 2019-01-10 Sale −2,200 $34.50 $75,900 4,078 I: show line 4 in the form
Open-market sales · 7,800 sh · avg $34.55 · $269,470
Loading xslF345X03/doc4.xml…